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In drug users, drug-related cues alone can induce dopamine release in the dorsal
striatum. Instructive cues activate inputs to the striatum from both dopaminergic and
cholinergic neurons, which are thought to work together to support motor learning
and motivated behaviors. Imbalances in these neuromodulatory influences can impair
normal action selection and might thus contribute to pathologically repetitive and
compulsive behaviors such as drug addiction. Dopamine and acetylcholine can have either
antagonistic or synergistic effects on behavior, depending on the state of the animal
and the receptor signaling systems at play. Semi-synchronized activation of cholinergic
interneurons in the dorsal striatum drives dopamine release via presynaptic nicotinic
acetylcholine receptors located on dopamine terminals. Nicotinic receptor blockade is
known to diminish abnormal repetitive behaviors (stereotypies) induced by psychomotor
stimulants. By contrast, blockade of postsynaptic acetylcholine muscarinic receptors in
the dorsomedial striatum exacerbates drug-induced stereotypy, exemplifying how different
acetylcholine receptors can also have opposing effects. Although acetylcholine release
is known to be altered in animal models of drug addiction, predicting whether these
changes will augment or diminish drug-induced behaviors thus remains a challenge. Here,
we measured amphetamine-induced stereotypy in BAC transgenic mice that have been
shown to overexpress the vesicular acetylcholine transporter (VAChT) with consequent
increased acetylcholine release. We found that drug-induced stereotypies, consisting of
confined sniffing and licking behaviors, were greatly increased in the transgenic mice
relative to sibling controls, as was striatal VAChT protein. These findings suggest that
VAChT-mediated increases in acetylcholine could be critical in exacerbating drug-induced
stereotypic behaviors and promoting exaggerated behavioral fixity.
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INTRODUCTION
Acetylcholine is a key intercellular signaling molecule that is
released from neurons in the central and peripheral nervous
systems as well as from non-neuronal cell types such as immune
and epithelial cells (Grando et al., 2007). Imbalances in CNS
acetylcholine have been documented in neurologic disorders
including Alzheimer’s disease and Parkinson’s disease, and also
in drug addiction. Enzymes required for acetylcholine synthesis
(ChAT, choline acetyltransferase), break-down (AChE, acetyl-
cholinesterase) and vesicular packaging (VAChT) are particularly
abundant in the striatum (Graybiel et al., 1986; Zhou et al.,
2001), a subcortical brain region that is important for motor
and motivational control and for habit formation (Jog et al.,
1999; Graybiel, 2008; Yin et al., 2009). Cholinergic interneu-
rons comprise only 1–2% of the total number of striatal neu-
rons but their processes, along with cholinergic input fibers
from brainstem nuclei (Dautan et al., 2014), span the striatum
(Graybiel et al., 1986; Kawaguchi, 1992). Furthermore, choliner-
gic interneurons are thought to correspond to the tonically active
neurons (TANs) that undergo semi-synchronous patterns of fire-
pause-rebound activity upon presentation of learned or salient
sensory cues (Kawaguchi, 1993; Aosaki et al., 1995; Matsumoto
et al., 2001; Inokawa et al., 2010; Schulz et al., 2011; Zhao et al.,
2011; Doig et al., 2014). The activity of these interneurons is
controlled by intrinsic membrane activity as well as a variety
of inputs, including excitatory inputs from the cerebral cortex
(Reynolds and Wickens, 2004; Doig et al., 2014) and the sensory-
responsive parafascicular nucleus of the thalamus (Lapper and
Bolam, 1992), local inhibitory input (Gonzales et al., 2013;
Doig et al., 2014), and modulatory inputs from cholinergic and
dopaminergic fibers (Aosaki et al., 1994; Dautan et al., 2014). All
together, these data are consistent with the notion that the cue-
related activity of cholinergic interneurons of the striatum serves
to re-bias action selection driven by cortico-basal ganglia circuits
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and their thalamic links (Minamimoto et al., 2009; Ding et al.,
2010).
Cholinergic interneurons are frequently located at the bor-
ders between striosomes (a.k.a. patches) and matrix, two stri-
atal compartments that have different input-output connections
(Gerfen, 1984; Jimenez-Castellanos and Graybiel, 1989; Langer
and Graybiel, 1989; Eblen and Graybiel, 1995; Kincaid and
Wilson, 1996; Fujiyama et al., 2011; Watabe-Uchida et al., 2012;
Gerfen et al., 2013) and that are impacted differentially by psy-
chomotor stimulants (Graybiel et al., 1990; Canales and Graybiel,
2000; Capper-Loup et al., 2002; Horner et al., 2012; Jedynak et al.,
2012) and disease (Crittenden and Graybiel, 2011). Preferential
disruption of striosomes by toxins or genetic targeting influences
the severity of drug-induced stereotypy (Tappe and Kuner, 2006;
Liao et al., 2008; Murray et al., 2013). Moreover, ablation of
cholinergic interneurons in the striatum blocks the drug-induced
striosome-to-matrix gene induction ratio (Saka et al., 2002)
and can increase drug-induced stereotypy (Aliane et al., 2011).
Together, these data suggest that the cholinergic system mediates
interactions between the two striatal compartments (Miura et al.,
2008), and the balance between drug-induced hyperlocomotion
and restricted, repetitive behaviors (Canales and Graybiel, 2000).
Overexpression of VAChT augments vesicular loading and
release of acetylcholine in vitro (Song et al., 1997). Moreover,
transgenic mouse models that carry multiple copies of Slc18a3,
the gene encoding VAChT, show an increase in evoked release
of acetylcholine in hippocampal slices (Nagy and Aubert, 2012;
Kolisnyk et al., 2013b). Transgenic mouse and rat lines that are
engineered to drive gene expression in cholinergic cells typically
carry exogenous copies of the cholinergic gene locus (Eiden,
1998) with an inactivated Chat gene but an intact Slc18a3 gene.
Accordingly, ChAT-ChR2-EYFP BAC mice, which were selected
for high-level expression of channelrhodopsin in cholinergic neu-
rons (Zhao et al., 2011), have been shown to overexpress VAChT
(Kolisnyk et al., 2013b). Evaluation of ChAT-ChR2-EYFP BAC
mice demonstrated that they have normal metabolic rate and
baseline locomotor activity but reduced performance in tests
for attention, spatial memory, cue-guided memory and working
memory (Kolisnyk et al., 2013b). Deletion of VAChT in the
prefrontal cortex of mice also disrupts cognitive function, as
reflected by reduced reversal learning and attention-task perfor-
mance (Kolisnyk et al., 2013a). Thus, both hypofunction and
hyperfunction of VAChT are associated with impairments in
cognitive function.
Here, we show that ChAT-ChR2-EYFP BAC mice have elevated
striatal VAchT and abnormally severe confined stereotypies when
treated with high doses of D-amphetamine. By contrast, they
showed mild hypersensitivity to low doses of D-amphetamine
and their behavioral responses to saline injection were relatively
normal. These data are consistent with the proposal that the
regulation of acetylcholine release is especially important for
balancing the response to extreme dopamine stimulation.
MATERIALS AND METHODS
MICE
The Committee on Animal Care at the Massachusetts Institute
of Technology approved all procedures. ChAT-ChR2-EYFP BAC
mice were genotyped from tissue assayed by Transnetyx, Inc. for
the presence of EYFP. ChAT-ChR2-EYFP BAC transgenic mice
(Zhao et al., 2011) were obtained from Prof. Guoping Feng on a
C57BL/6J genetic background and crossed to a line on a mixed
FVB/N and 129S4 background. Offspring were intercrossed to
maintain the line by crossing EYFP-positive mice to EYFP-
negative mice at every generation such that mice homozygous
for the transgene were never generated. For the data reported
here, ChAT-ChR2-EYFP BAC hemizygous mice were compared to
BAC-negative, sibling wildtype mice. Transgenic and control mice
were tested in parallel by an experimenter blinded to genotype.
All experimental mice were male and group-housed with sibling
controls under a standard light-dark cycle (lights on at 7 am and
off at 7 pm), with free access to food and water. Mice were between
3–11 months of age at the time of testing.
For the viral vector experiment to evaluate cholinergic
neuropil, male mice from the Cre knock-in line, B6;129S6-
ChAT<tm2(Cre)Lowl>/J (Rossi et al., 2011), were obtained from
Jackson Laboratories and used directly for experimentation.
INTRACEREBRAL VIRAL INJECTION
Adeno-associated virus (rAAV5EF1a-DIO-hChR2(E123T/
T159C)-mCherry) was packaged and purified by the Gene
Therapy Center Vector Core at The University of North Carolina
at Chapel Hill and estimated by dot blot to be at a concentration
of 4X10e12 virus molecules/ml.
Mice were anesthetized by injection (i.p., 10 ml/kg) with a
mixture of ketamine (120 mg/kg) and xylazine (16 mg/kg) in
saline. Mice were mounted onto a stereotactic frame and small
burr holes were made bilaterally (AP = 0.9 mm and ML = −1.9
mm and +1.9 mm, relative to bregma). A NanoFil microsyringe
(World Precision Instruments) was lowered to deliver 0.5 µl of
virus solution at each of two sites on each side of the brain (DV
= 2.0 mm and 2.7 mm), at a rate of 0.1 µl/min. Eight weeks
after surgery, mice were transcardially perfused and brain sections
were obtained for immunohistological examination as described
below.
IMMUNOLABELING AND HISTOLOGY
Mice were deeply anesthetized with Euthasol (pentobarbital
sodium and phenytoin sodium from Virbac AH Inc.) and per-
fused transcardially with 15 ml of saline followed by 60 ml of 4%
paraformaldehyde in 0.1 M NaKPO4, pH 7.4. Brains were post-
fixed overnight in 4% paraformaldehyde and then cryoprotected
by submersion overnight in 20% glycerin in 0.1 M NaKPO4,
pH 7.4. Frozen, 24-µm thick, transverse brain sections were
cut on a sliding microtome. Immunoreactivity was assessed by
standard methods. Briefly, free-floating sections were incubated
with primary antisera (anti-VAChT AB1588 from Millipore,
1:100 dilution; anti-ChAT AB144P from Millipore, 1:200 dilu-
tion; polyclonal anti-CalDAG-GEFI, 1:5,000 dilution Crittenden
et al., 2004). For immunofluorescence, sections were incubated
with secondary antibodies coupled to ALEXA594 or ALEXA488
(Invitrogen Corp., anti-rabbit, 1:250 dilution) and then were
mounted and coverslipped with Vectashield media (Vector Lab-
oratories). For non-fluorescent immunohistochemistry, sections
were incubated with a biotinylated secondary antibody (Vector
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Laboratories, anti-guinea pig and anti-goat, 1:500 dilution) the
signal was amplified and visualized by the Vectastain Peroxi-
dase ABC System (Vector Laboratories), and then sections were
mounted and coverslipped with Eukitt (Electron Microscopy
Sciences). Brightfield images were obtained on an Olympus BX61
microscope, and confocal images were obtained on a Nikon C2
microscope. EYFP and ALEXA488 fluorophores were excited with
a 488 nm solid-state laser and emission was transmitted through
a 560 nm short pass filter plus a 510 +/− 42 nm band pass filter.
mCherry and ALEXA594 were excited with a 561 nm solid-state
laser and emission was transmitted through a 648 nm short pass
filter plus a 593 +/− 20 nm band pass filter. High-resolution
confocal images were made by summing 5 µm (Figures 2D–F)
or 7.5 µm (Figures 2G–I) stacks of images taken at 0.5 µm
intervals. Images were processed and analyzed with Fiji soft-
ware (Schindelin et al., 2012). To ensure that the fluorescence
signal from cholinergic neuropil was within a striosome, and
not derived from matrix tissue above or below the image plane,
care was taken only to stack images in which the CalDAG-
GEFI immunoreactivity was consistently low within striosomal
borders.
IMMUNOBLOTTING
Mice were sacrificed by cervical dislocation, and the striatum
and overlying cerebral cortex were dissected on a cold plate
prior to freezing on dry ice and storage at −80◦C. To prepare
tissue lysates, frozen tissue was homogenized in ice-cold modified
RIPA buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1% Triton
X-100, 0.1% sodium dodecyl sulfate, 1% NaDeoxycholate) with
protease inhibitor, sodium fluoride, activated sodium orthovana-
date and PMSF and centrifuged at 16,000 × g for 10 min to
pellet insoluble material. The protein concentrations of super-
natants were determined by bicinchoninic acid assays (Pierce).
For detection of VAChT, lysates were not boiled prior to resolving
proteins by SDS-PAGE. Gel-resolved proteins were transferred to
PVDF membrane by using the Invitrogen iBlot. Immunoblotting
was accomplished by standard methods. Blots were incubated
overnight with antisera against VAChT (139103 from Synaptic
Systems, 1:500 dilution). Blots were rinsed and incubated with
horseradish peroxidase-coupled secondary antibody (Santa Cruz
Biotechnology, Inc. anti-rabbit, 1:5,000 dilution) prior to immun-
odetection with Immobilon Western (Millipore) according to
the manufacturer’s instructions. Blots were subsequently incu-
bated with anti-β-tubulin III (T8578 from Sigma-Aldrich Co.,
1:10,000 dilution) and horseradish peroxidase-coupled secondary
antibody (Santa Cruz Biotechnology, Inc. anti-mouse, 1:10,000)
to normalize total protein loading, as described in the Statistics
subsection below.
DRUGS
D-amphetamine (Sigma) was prepared fresh daily by dissolving
in saline, and mice were injected with 10 ml/kg (i.p.) for doses of
2.5 mg/kg/day or 7.0 mg/kg/day.
BEHAVIOR EVALUATION
Locomotor activity was measured using an activity monitoring
system and TruScan software (Coulbourn Instruments). Mice
were administered saline or drug individually in the activity
monitors, which consisted of 25 cm square × 40 cm high arenas
surrounded by Plexiglas walls. The floor consisted of a removable
plastic drop pan that was cleaned between sessions. A sensor
ring, housing 16 infrared beams to detect horizontal movements,
surrounded the arena. The animal position was measured every
100 ms, and the software calculated the distance traveled in 5-min
bins.
Mice were placed into the activity monitors and given 60 min
to habituate prior to injection. Following injection, mice were
placed back in the monitors for an additional 85 min of data
collection. On days 1–3, mice were injected with saline for habit-
uation to the treatment and environment. On days 4–10, mice
were treated with D-amphetamine. Mice were then given 7 days of
drug wash-out, with no treatment or handling, prior to a final D-
amphetamine challenge treatment. Each mouse received the same
dose of D-amphetamine on each day, and separate cohorts of mice
were used for the low- and high-dose D-amphetamine treatment
experiments. To test for sensitization to the injection procedure
itself, one cohort of D-amphetamine (7.0 mg/kg) treated mice was
given a challenge dose of saline, 12 days after the D-amphetamine
challenge. Mice were videotaped while in the monitors on saline
day 1, D-amphetamine treatment day 1, and on the challenge
day. Video recordings were 2-min long each, and they were taken
at 50 and 80 min after injection. An experimenter blinded to
genotype scored the videotapes using a keyboard scoring system
with the public domain software JWatcher™, version 1.0 (Uni-
versity of California, LA, CA, USA, and Macquarie University,
Sidney, Australia).1 Individual keys were assigned to score rest-
ing, grooming, locomotion, rearing, sniffing air, sniffing/licking
floor, sniffing/licking wall, no sniffing/licking and highly confined
stereotypy.
STATISTICS
To quantify immunoblot signals, VAChT immunoreactive bands
were selected in ImageJ software (Schneider et al., 2012), and
their density was measured and normalized to neuron-specific
tubulin bands on the same blot. Results were averaged across three
independent brain samples and compared by two-tailed Student’s
t-tests.
Distance traveled and rearing activity graphs are shown as the
mean + standard error of the mean for each genotype cohort of
mice. Summed distance traveled data (bar graphs in Figures 3–5)
from the Truscan recording system were compared between geno-
types by unpaired, two-tailed Student’s t-tests. Stereotypy scores
between genotype cohorts were compared by Mann-Whitney
U-tests. Significance criteria were set at p< 0.05.
RESULTS
OVEREXPRESSION OF VAChT IN THE STRIATUM OF ChAT-ChR2-EYFP
BAC TRANSGENIC MICE
VAChT protein products were elevated in striatum of ChAT-
ChR2-EYFP BAC transgenic mice, as illustrated by immunohis-
tochemistry in brain slices (Figures 1A,B) and by immunoblot
quantitation (Figure 1E). VAChT immunoreactivity was observed
1http://www.jwatcher.ucla.edu/
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FIGURE 1 | VAChT is overexpressed in the striatum and cerebral cortex of
ChAT-ChR2-EYFP BAC mice. VAChT (A,B) and ChAT (C,D) immunoreactivity
in coronal brain hemi-sections from a control mouse (A,C) and a hemizygous
ChAT-ChR2-EYFP BAC mouse (B,D). Corresponding high magnification
images at right show cholinergic interneurons located in the dorsomedial
striatum. Cx: cerebral cortex, DS: dorsal striatum, VS: ventral striatum, S:
septum, OT: olfactory tubercle. (E) Immunoblots and corresponding graphs
for VAChT expression in wildtype mice (WT) and sibling ChAT-ChR2-EYFP
BAC mice (Tg). Arrows point to VAchT-specific bands. Bar graphs represent
immunoreactivity based on densitometry of the upper VAChT-specific band,
relative to neuron-specific βIII-tubulin in wildtype (blue, n = 3) and
ChAT-ChR2-EYFP BAC (red, n = 3) mice. Values shown are mean + SEM.
in the cell bodies of cholinergic interneurons in both geno-
types and in small puncta throughout the striatum, consistent
with VAChT function in cell bodies and nerve terminals of
cholinergic neurons. Differentially intense VAChT immunoreac-
tive bands were observed at ∼70 kDa and ∼40 kDa, approx-
imating the size of products that were previously confirmed
to be missing in lysates from VAChT knockout mice (Nagy
and Aubert, 2012). The intermediate size bands, which were
not elevated in the BAC transgenic mice, were presumed to be
nonspecific. Immunoreactivity for ChAT appeared to be similar
in striatum of ChAT-ChR2-EYFP BAC transgenic mice, rela-
tive to controls (Figures 1C,D). Our results are consistent with
reports that, relative to controls, mRNA for VAChT is elevated
20-fold and mRNA for ChAT is unchanged in the striatum
of ChAT-ChR2-EYFP BAC transgenic mice (Kolisnyk et al.,
2013b).
CHOLINERGIC NEUROPIL DISTRIBUTION IN STRIOSOME AND MATRIX
COMPARTMENTS
The overexpression of enhanced yellow fluorescent protein
(EYFP) in cholinergic neurons of the ChAT-ChR2-EYFP BAC
transgenic mice provided an opportunity to detect fine neu-
ronal processes that could not be fully labeled with traditional
methods (Matsuda et al., 2009). To observe how cholinergic
neuropil was distributed relative to the striosome and matrix
compartments, we labeled striatal sections from the ChAT-ChR2-
EYFP BAC transgenic mice with red immunofluorescence for
the matrix marker, CalDAG-GEFI (Kawasaki et al., 1998) to
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FIGURE 2 | Cholinergic interneuron processes are differentially enriched
in striosome and matrix compartments of the striatum. (A–F) Confocal
images of cholinergic somata (arrows in A,C,D and F) and processes (green
fluorescence) in the dorsomedial striatum of a ChAT-ChR2-EYFP BAC
mouse. Striosomes are identified by low immunoreactivity for the matrix
marker CalDAG-GEFI (red immunofluorescence in B,C,E and F). Borders
between striosomes and matrix are designated by white lines in C and F.
(D–F) High-magnification confocal images of a striosome-matrix border,
showing thick, sparsley spiny processes (arrowheads in D and F), assumed
to be dendrites, that are mostly in the matrix compartment (right half of
panels). Very thin, EYFP-positive processes with varicosities, assumed to be
cholinergic axons, appear equally abundant in both striosomes (left half of
panels) and matrix. (G–I) High-magnification confocal images of the dorsal
striatum from a ChAT-Cre knock-in mouse with Cre-dependent mCherry (red
fluorescence) to label cholinergic interneurons (arrows in G and I).
CalDAG-GEFI immunofluorescence (green) defines the matrix compartment.
The medium-sized cell bodies with low CalDAG-GEFI immunoreactivity
(asterisks in the nuclei of example striosome cells in H and I) are within a
striosome (approximate border outlined in white). Thick cholinergic cell
processes (arrowhead in G and I) are abundant in the matrix and fine
processes with varicosities are dense in both the matrix and striosomes. S:
striosome; M: matrix; WB: White matter bundles.
compare to the pattern of EYFP fluorescence. We observed
that EYFP-positive cholinergic interneuron somata (arrows in
Figures 2A,C,D and 2F) were frequently in close proximity to
one another and to striosomal borders (Figures 2A–F) and,
although predominantly in the matrix, were occasionally located
within a striosome. Thick, sparsely-spiny, EYFP-positive processes
emanated from EYFP-positive cell bodies and were presumed
to be dendrites (arrowhead in Figures 2A,F). These putative
cholinergic interneuron dendrites sometimes appeared to cross
striosome-matrix borders, but were nevertheless more preva-
lent in the matrix than in the striosomes (Figures 2A–F). In
low-magnification images of the medial striatum, striosomes
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appeared as EYFP-poor zones (Figure 2A), presumably owing
to the matrix enrichment of these EYFP-positive dendrites, as
well as matrix-preferring EYFP-positive cholinergic fibers from
brainstem nuclei (Dautan et al., 2014). By high-resolution con-
focal microscopy, however, very thin, EYFP-positive processes
with varicosities, presumed to be axons, could be visualized
in both matrix and striosome compartments (Figures 2D–F),
as indicated in previous ChAT immunostaining methods ana-
lyzed with light microscopic methods (Graybiel et al., 1986),
but even more clearly seen here with confocal microscopy.
Thus the cholinergic neuropil of the striatum, although intense
in the matrix compartment, is differentiated, with potential
acetylcholine releases sites abundant in both striosomes and
matrix and dense dendritic arbors in the matrix compart-
ment.
To determine whether the distribution pattern of choliner-
gic neuropil that we observed might be unique to the ChAT-
ChR2-EYFP BAC transgenic mice, we examined cholinergic
interneurons in a ChAT-Cre knock-in line (Rossi et al., 2011)
that does not have duplication of the cholinergic gene locus.
To label the cholinergic interneurons in this line, we injected,
into the striatum of the mice, an adeno-associated virus that
carries a Cre-dependent gene encoding the red fluorophore,
mCherry (described in Section Materials and Methods). Eight
weeks after viral injection, we obtained brain sections and
double-labeled them by green immunofluorescence for the matrix
marker, CalDAG-GEFI. Compared to the ChAT-ChR2-EYFP BAC
mice, we observed fewer cholinergic interneurons labeled by this
method, and the cholinergic neuropil appeared less dense in most
regions. However, the compartmental distribution of labeled
processes was similar in the two lines (Figures 2G–I). In the
ChAT-Cre knock-in line, the thick, mCherry-positive processes
(presumed dendrites) crossed compartment borders but were
more abundant in the CalDAG-GEFI-positive zones (matrix),
than in the striosomes (CalDAG-GEFI-poor). By contrast, the
very fine mCherry-positive processes with varicosities (presumed
axons) appeared similarly dense between the striosome and
matrix compartments (Figures 2G–I). These results again sug-
gest that inputs to the cholinergic interneuron dendrites are
enriched in the striatal matrix (Herkenham and Pert, 1981;
Graybiel et al., 1986; Sadikot et al., 1992; Fujiyama et al., 2006;
Raju et al., 2006), whereas potential axon-terminal release sites
from cholinergic interneurons are dense in both striosomes and
matrix.
SEVERE DRUG-INDUCED STEREOTYPY IN ChAT-ChR2-EYFP BAC
TRANSGENIC MICE
To test whether the ChAT-ChR2-EYFP BAC transgenic mice had
abnormal responses to psychomotor stimulants, we measured
locomotion and stereotypy in transgenic mice and sibling controls
treated with low or high doses of D-amphetamine. To measure
locomotion each mouse was placed into an activity monitor fitted
with infrared photobeams to monitor mouse movements and
calculate distance traveled. To measure drug-induced stereotypy,
we video-recorded the mice for 2 min, at 50 and at 80 min post-
injection and a rater blinded to genotype scored the frequency and
duration of each behavior observed.
To habituate the mice to the activity chamber and also to
gather baseline behavior data, we injected the mice with saline (10
ml/kg, i.p.) for three consecutive days prior to drug treatment.
We found no differences in behavior between the ChAT-ChR2-
EYFP BAC transgenic mice and sibling controls injected with
saline in the novel chamber (Figures 3A,B). In response to the
first injection of low-dose D-amphetamine (2.5 mg/kg, i.p.), the
ChAT-ChR2-EYFP BAC transgenic mice showed a tendency for
a greater locomotor response than their sibling controls, but this
effect did not reach statistical significance (Figure 4A). The time
spent in slow versus fast locomotion was significantly less for
the transgenic mice, reflecting the tendency for their increase in
distance traveled (Figure 4B). To test for drug sensitization, we
treated the mice for an additional 6 days with the same dose
of D-amphetamine followed by a 7-day drug washout period
with no treatment, and then measured their response to a drug
challenge at the same dose-level. On the challenge day, both
transgenic and control mice showed evidence of sensitization in
that they began locomotion much sooner after drug injection
than they did on the first day (Figure 4C). The total distance
traveled did not appear increased on challenge day relative to
the first day of treatment, which is likely related to the increase
in pausing for wall-sniffing in the sensitized mice (Figure 4D
compared to 4B). On the challenge day, the transgenic mice
showed evidence of drug hyperresponsivity based on significantly
more time spent in fast locomotion than controls (Figure 4D).
Altogether, the ChAT-ChR2-EYFP BAC mice showed slight hyper-
sensitivy to low-dose D-amphetamine, both in their response
to acute treatment and after repeated treatment inducing drug
sensitization.
The response of the transgenic mice to high doses of D-
amphetamine (7.0 mg/kg) was strikingly different from that of
their wildtype siblings. The distance traveled scores of the trans-
genic mice started to fall sharply at the 20 min post-injection time
point (Figure 5A), as they began to engage in severe and confined
stereotypic behaviors such as sniffing the floor or the wall in the
corners of the monitors (Figure 5B). After repeated high-dose
D-amphetamine treatment, both transgenic and control mice
developed sensitized responses to the drug, indicated by their
short latencies to the onset of locomotion after drug-injection
(Figure 5C) and increase in severe stereotypy (Figure 5D), relative
to day 1. In summary, the ChAT-ChR2-EYFP BAC mice had
more severe confined stereotypic behavior, in both the naïve and
the drug-sensitized state, than the corresponding control mice
(Figures 5B,D).
Considering that cholinergic interneurons are reported to be
responsive to learned and salient cues, we also tested whether
the mice that had been sensitized to high-dose D-amphetamine
would show a sensitized locomotor response to saline injection
only. After drug sensitization, both ChAT-ChR2-EYFP BAC and
control mice showed a sharper response to saline injection than
they did prior to drug sensitization (Figure 6, compared to
Figure 3A), but there were no apparent differences between geno-
types. Thus, the transgenic mice did not exhibit blockade either
of behavioral sensitization to D-amphetamine injection itself or of
the capacity to become sensitized to cues associated with injection
of the drug.
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FIGURE 3 | Baseline locomotor measurements are normal in
ChAT-ChR2-EYFP BAC mice. (A) Distance traveled (mean + SEM) by
wildtype (blue, n = 13) and ChAT-ChR2-EYFP BAC (red, n = 15) mice in an
open-field chamber across time, around injection (dotted line) of saline at
time 0. The total distance traveled during an 85-min post-injection period is
shown in the bar graph. (B) Observational ratings of behaviors, averaged
for 50 and 80 min post-injection observation points, were equivalent in
transgenic mice and sibling controls.
FIGURE 4 | ChAT-ChR2-EYFP BAC mice show slightly increased
motoric responses to low-dose D-amphetamine. (A) Distance
traveled (mean + SEM) in an open-field chamber on the 1st day of
D-amphetamine injection (time 0, dotted line) for wildtype (blue, n = 6)
and ChAT-ChR2-EYFP BAC (red, n = 9) mice. The total distance traveled
post-injection (85 min) is shown in the bar graph. (B) Observational
rating of behaviors, averaged for 50 and 80 min post-injection
time-points, on D-amphetamine day 1. (C) Distance traveled
measurements and (D) observational ratings on the challenge day of
D-amphetamine treatment.
DISCUSSION
Our findings point to an abnormal behavioral phenotype in BAC
transgenic ChAT-ChR2-EYFP mice in which the mice exhibit
excessively severe amphetamine-induced stereotypy. It is likely
that this phenotype derives from overexpression of VAChT in
these mice. Consistent with the finding that Slc18a3 transcrip-
tion is elevated (Kolisnyk et al., 2013b), we observed signifi-
cantly higher VAChT protein immunolabeling in the striatum
and cerebral cortex of hemizygous transgenic mice than in their
littermate controls, as determined both by immunoblotting and
by immunohistochemistry. Thus, this BAC mouse line is likely
to have increased stimulated acetylcholine release in the stria-
tum, based on findings of increased release of acetylcholine in
hippocampal slices from this line and a second, similar line
(B6.eGFPChAT) (Nagy and Aubert, 2012; Kolisnyk et al., 2013b).
VAChT immunoreactivity appeared to be particularly abundant
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FIGURE 5 | Confined stereotypies are dramatically elevated in
ChAT-ChR2-EYFP BAC mice treated with high-dose D-amphetamine.
(A) Distance traveled (mean + SEM) in transgenic mice (red, n = 6) and in
wildtype controls (blue, n = 6) following the injection (dotted line) of high-dose
D-amphetamine on day 1. Total distance traveled after the injection (bar graph)
is significantly lower for the transgenic mice. (B) Observational rating of
behaviors on day 1 showed a significant increase in severely confined
stereotypies in transgenic mice relative to sibling controls. (C) Distance
traveled measurements and (D) observational ratings on the challenge day of
high-dose D-amphetamine treatment.
in the lateral striatum, which contains cholinergic interneurons
as well as cholinergic afferent fibers from the pedunculopontine
nucleus (Dautan et al., 2014), and excitatory inputs from sen-
sorimotor regions of the thalamus (Lanciego et al., 2004) and
neocortex (Kincaid and Wilson, 1996). Notably, this VAChT-
enriched region appears to be near to the ventrolateral zone
that induced the highest levels of oral stereotypy in a mapping
study made by local amphetamine injections across the striatum
(Dickson et al., 1994).
The VAChT overexpression finding is congruent with chro-
mosomal insertions of multiple copies of the ChAT-ChR2-EYFP
BAC construct (Zhao et al., 2011), in which the first part of the
Chat coding region was replaced by the ChR2-EYFP cassette,
but the Slc18a3 gene, which is located within intron 1 of Chat
(Eiden, 1998), was not altered. A similar BAC construct design
has been used to generate numerous transgenic rodent lines in
order to drive gene expression in cholinergic cells. Such transgenic
lines include a channelrhodopsin line (Ren et al., 2011; Zhao
et al., 2011), a ribosomal L10a marker TRAP line (Doyle et al.,
2008; Heiman et al., 2008), fluorescent reporter lines (Gong et al.,
2003), a tau-GFP line (Grybko et al., 2011), mouse Cre lines
(Gong et al., 2007), and a rat Cre line (Witten et al., 2011).
ChAT BAC lines selected for high transgene expression levels
would be expected to have correspondingly high expression of
VAChT. Knock-in lines in which the transgene is targeted to the
endogenous ChAT locus (Rossi et al., 2011), or BAC transgenic
lines in which VAChT is specifically inactivated (Ting and Feng,
2014), could be the exceptions. It is well-recognized that the
genetic background (Thomsen and Caine, 2011), as well as the
sex, age and housing conditions of mice influence their responses
to psychomotor stimulants. The phenotype of the BAC mice
described here highlights the importance of controlling for the
possibility that BAC transgenic mice carry extra copies of genes or
have a gene mutation caused by chromosomal insertion of the
BAC. Abnormal responses to cocaine were discovered for a Drd2-
EGFP BAC mouse line as well (Kramer et al., 2011), although this
phenotype is reported to be sensitive to genetic background and
is dependent on homozygosity for the BAC insertion (Chan et al.,
2012).
The fluorophore overexpression in the ChAT BAC transgenic
mice, and virus-injected ChAT-Cre knock-in mice, permitted
us to observe the cholinergic neuropil in fine detail. The den-
drites that originated from the fluorophore-labeled cholinergic
interneurons were sparsely spiny and were more prevalent in
the matrix compartment than in the striosomes of the dorsome-
dial striatum (Graybiel et al., 1986). This finding complements
evidence that the thalamic parafascicular nucleus preferentially
targets the striatal matrix, and is a major source of input to
the dendritic shafts of cholinergic interneurons (Herkenham
and Pert, 1981; Lapper and Bolam, 1992; Sadikot et al., 1992;
Fujiyama et al., 2006; Raju et al., 2006). The compartmentalized
distribution of EYFP-positive dendrites was most obvious in
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FIGURE 6 | Responses of amphetamine-sensitized mice to saline
injection were equivalent between genotypes. Wildtype (blue, n = 6)
and transgenic (red, n = 6) mice that were previously treated with repeated
D-amphetamine (7 mg/kg) injections showed similar sensitized locomotor
responses to saline injection (dotted line).
the striosome-rich medial striatum, a region specifically impli-
cated in the cholinergic regulation of drug-induced stereotypy
(Aliane et al., 2009). In contrast to the matrix-enrichment of
dendrites from the cholinergic interneurons, very thin, EYFP-
positive cholinergic processes, with abundant varicosities typical
of axons, extended throughout both the matrix and striosomes,
a finding strongly extending the original observation of this fine
intra-striosomal neuropil (Graybiel et al., 1986). This apparent
innervation of striosomes by the fine fibers of striatal cholin-
ergic neurons contrasts with the reported minimal innervation
of striosomes by inputs arising from cholinergic neurons in the
brainstem, which strongly and preferentially innervate the matrix
compartment (Dautan et al., 2014). If verified by further co-
labeling of these two sources of cholinergic input to the striatum,
these results together would suggest that direct cholinergic inner-
vation of striosomes likely arises specifically from the cholinergic
interneurons.
AChE, the main degradative enzyme of acetylcholine, is
enriched in the matrix in humans (Graybiel and Ragsdale, 1978),
bringing up the further possibility that acetylcholine signaling is
more transient in the matrix than in striosomes. Although such
differential AChE distributions are scarcely visible in the rodent
striatum, preferential striosomal expression of c-Fos is induced by
high-dose amphetamine treatment in both rodents and monkeys
in vivo (Graybiel et al., 1990; Canales and Graybiel, 2000; Saka
et al., 2004; Horner and Keefe, 2006; Jedynak et al., 2012) and this
compartmentalized pattern is disrupted by ablation of cholinergic
interneurons (Saka et al., 2002). Together with our immunflu-
orescence findings, these observations suggest that acetylcholine
release could directly and differentially influence the striosome
and matrix compartments.
The ChAT-ChR2-EYFP BAC transgenic mice suffered severe
stereotypy, both after acute administration of D-amphetamine
and after repeated administration of this drug. There is abun-
dant evidence that changes in acetylcholine levels in the stria-
tum are linked to drug-induced stereotypy. In vivo microdialysis
studies in behaving rats show that acute, binge methamphetamine
treatment protocols that induce high levels of stereotypy lead to
changes in acetylcholine release in the dorsal striatum, relative
to pre-drug levels. Rats that are given prolonged, repeated drug
treatments that result in tolerance to the stereotypy-inducing
effects of methamphetamine have less repression of acetylcholine
release (Kuczenski and Segal, 2001). By contrast, the levels of
acetylcholine in the ventral striatum are not different in rats that
show tolerance versus sensitization to drug-induced stereotypy
(Kuczenski and Segal, 2001), supporting the idea that drug-
induced stereotypy is related to activity in the dorsal striatum.
Other microdialysis studies, however, suggest that rats exhibit-
ing a sensitized stereotypic responses to amphetamine have an
increase in striatal acetylcholine (Bickerdike and Abercrombie,
1997), rather than a decrease. The reasons for these opposing
effects of psychomotor stimulants on acetylcholine levels are
unclear (Kuczenski and Segal, 2001), but the studies nevertheless
converge to show a strong correlation of behavioral stereotypy
with changes in striatal acetylcholine.
This relationship between acetylcholine and drug-induced
stereotypy is still not understood at a mechanistic level. Phar-
macologic studies indicate that stereotypy can be influenced by
postsynaptic muscarinic receptors as well as presynaptic nico-
tinic acetylcholine receptors. One potential mechanistic link
comes from the fact that activation of presynaptic β2 nicotinic
acetylcholine receptors, under certain conditions, can enhance
dopamine release from terminals in the dorsal striatum (Zhou
et al., 2001; Perez et al., 2009; Threlfell et al., 2012) and that
drug-induced stereotypy is associated with co-activation of D1-
and D2-type dopamine receptors (Capper-Loup et al., 2002).
Moreover, repeated nicotine administration induces stereotypy in
rats and also enhances behavioral responses to cocaine (Collins
and Izenwasser, 2004). Notably, two studies show that DHβE
administration in mice reduces sensitization of stereotypies in
response to repeated drug administration, but does not change
the stereotypy in response to first-time drug exposure (Karler
et al., 1996; Metaxas et al., 2012), suggesting that β2 nicotinic
receptors are important for sensitization of stereotypy, but not for
the acute stereotypic response. Collectively, these findings raise
the possibility that ChAT-ChR2-EYFP BAC transgenic mice are
“born sensitized” by virtue of having molecular abnormalities
that are similar to those in sensitized animals, and that this pre-
disposition biases them toward exhibiting an increased response
to their first D-amphetamine exposure, without being so severe as
to occlude further sensitization.
VAChT is reported to be up-regulated in post-mortem stri-
atal samples from human methamphetamine users (Siegal et al.,
2004), suggesting that humans exposed to drugs of abuse might
have abnormal acetylcholine release akin to that in rodent models
of drug addiction (Bickerdike and Abercrombie, 1997; Kuczenski
and Segal, 2001) and in transgenic mice with VAChT overexpres-
sion (Nagy and Aubert, 2012; Kolisnyk et al., 2013b). Considering
the findings reported here of increased responses to a habit-
forming psychomotor stimulant in mice that ovexpress VAChT,
dysregulation of VAChT in humans might be directly related to
drug addiction. Reversible AChE inhibitors are prescribed for
medical conditions of reduced acetylcholine function including
myasthenia gravis and Alzheimer’s disease (Nair and Hunter,
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2004). AChE inhibitors are also under investigation for the treat-
ment of methamphetamine addiction (De La Garza et al., 2012)
and motor tics in Tourette syndrome (Cubo et al., 2008). Despite
the widespread use of compounds that reduce the breakdown of
acetylcholine, there is incomplete information about the effects of
augmenting acetylcholine release. The distinction between these
two approaches for elevating acetylcholine may an important one,
considering that the phasic release of acetylcholine is thought to
be important for cognitive attention (Sarter et al., 2009) and that
there are profound differences between tonic and phasic release of
dopamine (Goto et al., 2007; Schultz, 2007). Whether stimulation
or overexpression of VAChT could be beneficial for particular
medical conditions remains to be tested.
The functions of acetylcholine in the striatum depend upon
a multitude of factors including the differential activation and
dynamics of acetylcholine receptor subtypes, the striatal region
under study, and the firing patterns of the dopamine-containing
neurons innervating the striatum (Morris et al., 2004; Perez et al.,
2009; Threlfell and Cragg, 2011; Zhang and Sulzer, 2012). More-
over, these neuromodulatory influences are themselves associated
with functions in numerous neural circuits and cell types. We
highlight the severe stereotypic behavior of the ChAT-ChR2-
EYFP BAC transgenic mice because of its striking potential reflec-
tion of the power of the striatal cholinergic system to influ-
ence repetitive behaviors induced by habit-forming drugs. This
strong overexpression phenotype suggests that the cholinergic
system is poised to regulate responses to intense dopaminergic
stimulation, conditions engendered by drug use. Cell signaling
mechanisms across the body are relevant to an animal’s response
to drugs of abuse, and how the loss of frontal control contributes
to addiction (Feil et al., 2010) may be related to how cue-
sensitivity, motivation, and memory are integrated (Flagel et al.,
2009).
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